Kim Young Hwan, Choi Joon Young, Do In-Gu, Kim Sung, Kim Byung-Tae
*From the Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul; †Department of Nuclear Medicine, Hanyang University Guri Hospital, Hanyang University School of Medicine, Guri; and Departments of ‡Pathology and §Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.†Department of Nuclear Medicine, Hanyang University Guri Hospital, Hanyang University School of Medicine, Guri; and Departments of ‡Pathology and § Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
J Comput Assist Tomogr. 2013 Sep-Oct;37(5):815-9. doi: 10.1097/RCT.0b013e3182972989.
We assessed factors affecting fluorine F 18 fluorodeoxyglucose (F-FDG) uptake of metastatic lymph nodes (LNs) in advanced gastric cancer (AGC) due to low F-FDG uptake of metastatic LNs in gastric cancer.
Retrospective analyses were performed on 31 patients with AGCs who underwent preoperative F-FDG positron emission tomography (PET) and subsequent gastrectomy. Metastatic LNs were compared with primary tumors (on a one-to-one basis) with respect to maximum standardized uptake values, glucose transporter type 1 (GLUT-1) expression, proliferation indices (using Ki-67), microvessel density, and lymphatic vessel density.
Maximum standardized uptake values of metastatic LNs were significantly correlated with % GLUT-1 expression (ρ = 0.80, P < 0.0001) and Ki-67 labeling index (ρ = 0.57, P = 0.001) in LNs. These uptake values were also significantly correlated with SUVs (ρ = 0.54; P = 0.002), % GLUT-1 expression (ρ = 0.71, P < 0.0001), and Ki-67 labeling index (ρ = 0.43, P = 0.019) in primary tumors. In multiple regression analysis, only % GLUT-1 expression in primary tumors and metastatic LNs were significant factors in predicting maximum standardized uptake value of metastatic LNs.
In AGCs, GLUT-1 expression and Ki-67 labeling index are important factors in predicting F-FDG uptake by metastatic LNs.
由于胃癌转移淋巴结的氟代脱氧葡萄糖(F-FDG)摄取较低,我们评估了影响晚期胃癌(AGC)转移淋巴结F-FDG摄取的因素。
对31例行术前F-FDG正电子发射断层扫描(PET)及随后胃切除术的AGC患者进行回顾性分析。将转移淋巴结与原发肿瘤(一对一)在最大标准化摄取值、葡萄糖转运蛋白1型(GLUT-1)表达、增殖指数(使用Ki-67)、微血管密度和淋巴管密度方面进行比较。
转移淋巴结的最大标准化摄取值与淋巴结中GLUT-1表达百分比(ρ = 0.80,P < 0.0001)和Ki-67标记指数(ρ = 0.57,P = 0.001)显著相关。这些摄取值还与原发肿瘤中的SUV(ρ = 0.54;P = 0.002)、GLUT-1表达百分比(ρ = 0.71,P < 0.0001)和Ki-67标记指数(ρ = 0.43,P = 0.019)显著相关。在多元回归分析中,仅原发肿瘤和转移淋巴结中的GLUT-1表达百分比是预测转移淋巴结最大标准化摄取值的重要因素。
在AGC中,GLUT-1表达和Ki-67标记指数是预测转移淋巴结F-FDG摄取的重要因素。